Healthcare & Life Sciences
SynOx Therapeutics
Germanysynoxtherapeutics.com
SynOx Therapeutics is a Healthcare & Life Sciences startup based in Germany, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
2020
Founded
1
Investors
About SynOx Therapeutics
SynOx Therapeutics is a company founded in 2020 headquartered in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
SynOx Therapeutics is a clinical-stage company developing emactuzumab, a next-generation monoclonal antibody targeting CSF-1R to treat tenosynovial giant cell tumours (TGCT) and other macrophage-driven diseases.
Explore SynOx Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.